Funded Tech Companies

Rgenta Therapeutics

Rgenta Therapeutics is a leading biopharmaceutical tech company, based in Cambridge. Venture investment and financing was provided by AstraZeneca, Korea Investment Partners and Delos Capital.

Company Overview

Company Name
Rgenta Therapeutics
Company Status
Private & Independent
Funding Rounds

Contact Information

Mailing Address
700 Main St. LabCentral
Cambridge, MA 02139
USA
Phone
Undisclosed
Email Address

Company Background Information

Overview
Rgenta Therapeutics is developing a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology and neurological disorders. Our proprietary platform mines the massive genomics data to identify targetable RNA processing events and design small-molecule glues to modulate the interactions among the spliceosome, regulatory proteins, and RNAs.
Profile
Rgenta Therapeutics LinkedIn Company Profile
Social Media
Rgenta Therapeutics Company Twitter Account
Company News
Rgenta Therapeutics News
Facebook
Rgenta Therapeutics on Facebook
YouTube
Rgenta Therapeutics on YouTube
Last Transaction
11/29/2022

Financing History

Date
Type
Amount
Venture Equity
$52,000,000
Venture Equity
$20,000,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Simon Xi
  Simon Xi LinkedIn Profile  Simon Xi Twitter Account  Simon Xi News  Simon Xi on Facebook
Chief Scientific Officer
Travis Wager
  Travis Wager LinkedIn Profile  Travis Wager Twitter Account  Travis Wager News  Travis Wager on Facebook


Company Investors

 

 

 

Browse more funded tech companies:

RGB Networks | RGFREE

 

Share this article

 


About Our VC Deals Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary